ArticleCancers2019

Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo.

Yusuf A Haggag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.